AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $139 | -15.8% | 14 | 0.0% | 0.00% | – |
| Q1 2024 | $165 | -91.6% | 14 | -89.9% | 0.00% | – |
| Q4 2023 | $1,973 | -78.3% | 139 | -80.8% | 0.00% | -100.0% |
| Q2 2023 | $9,106 | +13.2% | 725 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $8,041 | – | 725 | +2489.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 28 | -95.8% | 0.00% | -100.0% |
| Q1 2022 | $6,000 | -25.0% | 668 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $8,000 | +14.3% | 668 | -11.1% | 0.00% | 0.0% |
| Q3 2021 | $7,000 | 0.0% | 751 | +9.8% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | 0.0% | 684 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | -56.2% | 684 | -2.8% | 0.00% | -66.7% |
| Q4 2020 | $16,000 | +60.0% | 704 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $10,000 | 0.0% | 704 | +2.9% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | +66.7% | 684 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $6,000 | -25.0% | 684 | -19.6% | 0.00% | 0.0% |
| Q4 2019 | $8,000 | – | 851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 9,029,843 | $89,576,043 | 10.38% |
| Perceptive Advisors | 28,057,456 | $278,329,964 | 6.70% |
| Redmile Group, LLC | 10,595,089 | $105,103,283 | 6.36% |
| STEMPOINT CAPITAL LP | 1,495,047 | $14,830,866 | 4.36% |
| CM Management, LLC | 450,000 | $4,464,000 | 4.10% |
| Avoro Capital Advisors LLC | 27,400,000 | $271,808,000 | 3.62% |
| GREAT POINT PARTNERS LLC | 1,495,500 | $14,835,360 | 2.84% |
| Saturn V Capital Management LP | 713,536 | $7,078,277 | 2.68% |
| AlphaCentric Advisors LLC | 202,500 | $2,008,800 | 1.48% |
| Novo Holdings A/S | 2,500,000 | $24,800,000 | 1.44% |